Small cell lung cancer: state of the art and future perspectives.
about
Identification of the 'NORE' (N-Oct-3 responsive element), a novel structural motif and composite element.Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy.Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer.Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer.The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung CancerDiffusion-weighted imaging vs STIR turbo SE imaging: capability for quantitative differentiation of small-cell lung cancer from non-small-cell lung cancer.Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA.Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancerEpidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung.Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysisApparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis.Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice.Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases.Immunotherapy treatments for small-cell lung cancer: past, present and future.Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center ExperienceIrinotecan in the treatment of small cell lung cancer: a review of patient safety considerations.Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer.The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer.Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort.Immunotherapy in lung cancer.Immunotherapy prospects in the treatment of lung cancer and mesothelioma.Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort.Lung Cancer Staging and Prognosis.Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study.Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.Prognosis of small cell lung cancer patients with diabetes treated with metformin.A phase II study of S-1 in relapsed small cell lung cancer.Indomethacin-enhanced anticancer effect of arsenic trioxide in A549 cell line: involvement of apoptosis and phospho-ERK and p38 MAPK pathwaysTreatment update in small-cell lung cancer: from limited to extensive disease.Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.HRCT findings of small cell lung cancer measuring 30 mm or less located in the peripheral lung.The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.[Clinical analysis of 80 patients with combined small-cell lung cancer].A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer.
P2860
Q24802996-55622DE8-5F8B-4619-81B4-4AFBBCF5C1DCQ27021829-29D8EE89-10E4-4B06-BBFF-8B151E5AF127Q31111719-7703075D-4EF8-489D-993D-E8AB6CF753D0Q33384024-AD0BC6A2-5E8B-4E34-8F63-0CBB37C4251FQ33393176-924EC575-444D-4A03-96E0-63D808F12451Q33599044-8F33E0A5-5DA7-4BE2-B3C2-FB2BC6E16A2FQ33747929-FA5A03FD-9391-40AD-BAFC-843DC0EEF076Q33823101-1F0C3960-7721-46EE-A70A-B8911269709EQ34396256-87C7A700-D7C4-4603-B53F-9A1CB39E977BQ34502009-5C934011-4774-4EAA-A78E-2A49109E7764Q34676580-1703E5AD-20D9-4E8B-933B-0BFFC0DC6224Q35384553-92D65C0A-5C45-44AF-8F2E-F1D0BD1512C2Q35640148-D4A8B7A4-AB3B-4755-98B3-5DC7250336DEQ35731542-9F7A4B72-4666-443F-8B42-8B8F27D5F2D6Q35824126-04415B10-CF68-4919-82B3-A07232EB39BAQ35904003-9B12ECD8-1DB5-49F5-A0B5-4E0B56A146CCQ35984458-689793C3-237C-4360-AE40-2929DD09354AQ36190145-731C8F16-E0C2-4361-8C55-EB90E485CC86Q36407286-80FD9A4A-0478-495D-8A95-8144602D2677Q36614403-58450CF8-BFA9-4105-A983-6046EC320F41Q37015297-6370FA14-EACA-495B-8768-3061956B1E6DQ37376246-A04AE97C-5AD8-41DD-81AB-AA11B03130C0Q37427934-C9F2FB3E-A969-47D0-9E6A-9732A0DF3A1AQ38390093-D8D6C8B5-8E17-445B-AA16-78A03D952E0FQ38390104-99F009A2-06C2-47CF-8591-149067B0711AQ38791807-36AFFBB2-65A0-4CA9-846D-44E41EA161B7Q38830349-8246DA7F-31E3-4DE0-9E88-E0B7ECC22B82Q39260743-CD75A49F-C3B4-4B9E-831E-DF7712CF97EAQ39412383-699293AB-2348-4EC2-A057-CD10C0923B6FQ40847551-4819DF54-7EEB-42A0-9E10-9DAF9F6C46B6Q41921557-494339F3-3D5C-4ADA-B3C8-778E752CC4A4Q42095313-EFAC4816-A5D9-4CC5-9119-F002818001DBQ43939698-439DA534-2EDD-4B65-A25B-5E5E1E9DCFDDQ47159086-80E188FC-0491-4611-ABBA-ECCEB29C79D1Q53161422-CBA0F705-126D-4756-BEBE-4244F5D15DC0Q54388835-4D632636-B9E3-4A76-90A1-BB364967CFABQ55425585-F007DEFA-375D-4271-882D-71BFA18283B6Q55426764-2FB65C02-CC3E-401C-A3E7-FEBAD917131F
P2860
Small cell lung cancer: state of the art and future perspectives.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Small cell lung cancer: state of the art and future perspectives.
@ast
Small cell lung cancer: state of the art and future perspectives.
@en
Small cell lung cancer: state of the art and future perspectives.
@nl
type
label
Small cell lung cancer: state of the art and future perspectives.
@ast
Small cell lung cancer: state of the art and future perspectives.
@en
Small cell lung cancer: state of the art and future perspectives.
@nl
prefLabel
Small cell lung cancer: state of the art and future perspectives.
@ast
Small cell lung cancer: state of the art and future perspectives.
@en
Small cell lung cancer: state of the art and future perspectives.
@nl
P2093
P1433
P1476
Small cell lung cancer: state of the art and future perspectives.
@en
P2093
Andrew T Turrisi
Christian Monnerat
Michael C Perry
Roger Stupp
Serge Leyvraz
P304
P356
10.1016/J.LUNGCAN.2003.12.006
P577
2004-07-01T00:00:00Z